Market Access

Rare Diseases: Building Long Term Relationships

October 15, 2020

Therapeutic companies that work with rare diseases must take early steps to build relationships with patients, caregivers, and HCPs.

Commercializing an Orphan Drug: Why “Just” Serving a High Unmet Medical Need Won’t Do the Job

September 08, 2020

Looking at four building blocks of success, Wolfram Lux and Simone Seiter investigate what it takes to win and be successful when commercializing an orphan drug

Reimbursement Benchmark Share: An Objective Measure of the Impact of Product Reimbursement on Sales Performance

August 07, 2020

Knowing that product reimbursement affects performance and varies by geography, this article proposes the use of Reimbursement Benchmark Share (RBS) to quantify the influence of reimbursement on a product’s performance.

Drive for COVID-19 Therapies Raises Patent and Pricing Issues

May 16, 2020

Pharmaceutical Executive

Proposals around the globe seek to ensure access to any promising treatments.